RE:RE:Could generate $120 mil/yr additional revenue for AphriaI just read the entire 29 page article from BOC. Wow. They've worked closely with Aphria and at the moment there's no reason to think Aphria isn't one of the 10+ cannabis companies they are trialing with. I'm also cautious that 2018 is another year we wait on trial results but the share price won't stay this low much longer. Looking to buy more. GLTA.